In brief: National Institute for Clinical Excellence
The National Institute for Clinical Excellence has ruled that taxanes Taxotere and Taxol can be used to treat advanced breast cancer where other drugs have not worked or are unsuitable. The Association of the British Pharmaceutical Industry welcomed the decision , but said it should have been reached without the ...
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here